Decapeptid effect in myoma

Not Applicable

• Conditions: Myoma.; Myoma; M8895/0

• Registration Number: IRCT201012045307N1
• Lead Sponsor: Vice Chancellor for Research, Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Included:Age between 18 to50 years old; myoma size equal or more than 5cm with abnormal vaginal bleeding, unexplained inferility, pelvic pain, dysmenorrea and signs related to mass.
Exclusion criteria: Multiple myoma size more than 2cm and hormonal therapy during last month
major disease

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
terus myoma size. Timepoint: Baseline, weeks 2, 4, 6 and 12. Method of measurement: Myoma size with transvaginal sonography(cm).

Secondary Outcome Measures

Name	Time	Method
Dysuria. Timepoint: Weeks 2, 4, 6 and 12. Method of measurement: Questionnaire.;Flushing. Timepoint: Weeks 2, 4, 6 and 12. Method of measurement: Questionnaire.;Dryness of vagina. Timepoint: Weeks 2, 4, 6 and 12. Method of measurement: Questionnaire.;Dysparunia. Timepoint: Weeks 2, 4, 6 and 12. Method of measurement: Questionnaire.